Public offering nets Checkpoint Therapeutics $18.4mm

15:40 EDT 12 Mar 2018 | Elsevier Business Intelligence

Checkpoint Therapeutics Inc. (immuno-oncology) netted $18.4mm through the public sale of 4.6mm common shares at $4.35. Funds ...

Original Article: Public offering nets Checkpoint Therapeutics $18.4mm

NEXT ARTICLE

More From BioPortfolio on "Public offering nets Checkpoint Therapeutics $18.4mm"